A randomised trial of effective and cost effectiveness of supervised versus unsupervised administration of buprenorphine-naloxone for heroin dependence
Phase 3
Completed
- Conditions
- Heroin dependenceMental Health - Addiction
- Registration Number
- ACTRN12607000285459
- Lead Sponsor
- angton Centre
- Brief Summary
Not available
- Detailed Description
Not available
Recruitment & Eligibility
- Status
- Completed
- Sex
- All
- Target Recruitment
- 146
Inclusion Criteria
DSM-IV diagnosis of heroin dependence. 12 month history of dependence. Stable housing.
Exclusion Criteria
Dependence on alcohol, amphetamines, or benzodiazepines.Major medical or psychiatric conditions. Methadone or buprenorphine treatment in the past month. Risk of incarceration.Pregnant/planning pregnancy. Previous enrolment in study.
Study & Design
- Study Type
- Interventional
- Study Design
- Not specified
- Primary Outcome Measures
Name Time Method
- Secondary Outcome Measures
Name Time Method